PMAIP1 Enhances DNA Damage and Induces ROS‐Mediated Mitochondrial Dysfunction to Suppress Tumorigenesis in Triple‐Negative Breast Cancer
The Breast Journal · 2025
DOI: 10.1155/tbj/7056712 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Breast Journal, 2025. Verfasst von Fangjian Shang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, 050023, Hebei, China, hebmu.edu.cn. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, DNA Damage, Mitochondria, Reactive Oxygen Species. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, Hebei Medical University.
Abstract (Originalsprache)
Background
PMAIP1 (NOXA) is a pro‐apoptotic factor that is closely related to cancer development, but its role in triple‐negative breast cancer (TNBC) is unclear. This study aimed to explore the effect of PMAIP1 on TNBC cell viability, apoptosis, DNA damage, and mitochondrial function. Methods qRT‐PCR and western blot were used to detect the expression level of PMAIP1 in TNBC tissues and cells, and its biological role was evaluated in combination with MTT, TUNEL, comet assay, and mitochondrial function indicators (ROS, ATP, mtDNA, and JC‐1).
Results
PMAIP1 is significantly upregulated in TNBC and is negatively correlated with cell viability: Overexpression of PMAIP1 inhibits cell viability, while knockdown of PMAIP1 enhances viability. Upregulation of PMAIP1 promotes apoptosis by increasing the Bax/Bcl‐2 ratio, induces DNA damage, elevates ROS levels, and reduces ATP, mtDNA, and JC‐1 levels, leading to mitochondrial dysfunction; conversely, knockdown of PMAIP1 alleviates these changes.
Conclusion
PMAIP1 exerts a tumor suppressor effect by regulating apoptosis, DNA damage, and mitochondrial dysfunction, providing potential target support for the treatment of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, 050023, Hebei, China, hebmu.edu.cn.
- School of Basic Medical Sciences, First Affiliated Hospital of Xingtai Medical College, Xingtai, 054099, Hebei, China.
- Department of Gland Surgery, Hebei General Hospital, Shijiazhuang, 050051, Hebei, China, hebmu.edu.cn.
- School of Basic Medical Sciences, Xingtai Medical College, Xingtai, 054000, Hebei, China.
- Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China, hebmu.edu.cn.
ORCID-Profile: Fangjian Shang, Yixin Qi, Liyan Zhao
Förderung
- Natural Science Foundation of Hebei Province
- Hebei Medical University
Zitieren
APA
Shang, F., Xu, L., Liu, H., Dong, X., Wu, H., Yin, L., Yan, L., Qi, Y., & Zhao, L. (2025). PMAIP1 Enhances DNA Damage and Induces ROS‐Mediated Mitochondrial Dysfunction to Suppress Tumorigenesis in Triple‐Negative Breast Cancer. The Breast Journal. https://doi.org/10.1155/tbj/7056712
Vancouver
Shang F, Xu L, Liu H, Dong X, Wu H, Yin L, et al. PMAIP1 Enhances DNA Damage and Induces ROS‐Mediated Mitochondrial Dysfunction to Suppress Tumorigenesis in Triple‐Negative Breast Cancer. The Breast Journal. 2025. doi:10.1155/tbj/7056712
BibTeX
@article{Shang2025,
author = {Shang, Fangjian and Xu, Lei and Liu, Hongzhi and Dong, Xin and Wu, Huangfei and Yin, Liping and Yan, Lijuan and Qi, Yixin and Zhao, Liyan},
title = {PMAIP1 Enhances DNA Damage and Induces ROS‐Mediated Mitochondrial Dysfunction to Suppress Tumorigenesis in Triple‐Negative Breast Cancer},
journal = {The Breast Journal},
year = {2025},
doi = {10.1155/tbj/7056712}
}
EUVIMED